{"meta":{"status":200,"messages":[],"pagination":{"max":1,"offset":0,"count":1,"total":1,"pageNum":1,"totalPages":1,"sort":null,"currentUrl":"https://api.digitalmedia.hhs.gov/api/v2/resources/media.json?offset=0&max=1&ignoreHiddenMedia=1&format=json&id=4527&newUrlBase=http://www.cdc.gov/flu/about/qa","nextUrl":null,"previousUrl":null}},"results":[{"content":"
\nQuestions & Answers
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\nStaphylococcus aureus, often referred to simply as \u201cstaph,\u201d are bacteria commonly carried on the skin or in the nose of healthy people. Staph bacteria frequently cause skin infections, such as boils. Most of these infections are not life-threatening.
\nIn addition to skin infections, staph bacteria can cause infections in the blood, in the bones and in the lungs (pneumonia). Most serious staph bacterial infections are treated with an antibiotic related to penicillin. However, over the past 50 years, some staph bacteria have become resistant to antibiotics, including the commonly used penicillin-related antibiotics. These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA.
\nThe overall risk of developing an MRSA infection after influenza appears to be very low. However, CDC continues to work with state and local public health authorities to better understand this association.
\nCDC is working with state and local public health authorities to monitor and investigate infections with MRSA, including pneumonias and other types of MRSA infections that occur in patients with influenza. CDC also acts as a technical advisor to state and local health departments and various professional organizations that are working to control MRSA.
\nIn 2008, CDC launched the National MRSA Education Initiative to provide information on recognition, prevention, and treatment of these infections. Visit the CDC MRSA web site for more information about this initiative.
\n